News

Smithsonian Magazine: A Lesser-Known Psychedelic Drug Shows Promise for PTSD Treatment

Ibogaine, derived from a central African shrub, has been used in rituals for two millennia. But in a small study, it appeared to reduce symptoms of PTSD among veterans

THE INTERCEPT: CONGRESS IS PUSHING REVOLUTIONARY RESEARCH ON PSYCHEDELIC TREATMENTS FOR THE MILITARY

A provision in the annual defense bill would have the Pentagon run clinical trials for members of the military with post-traumatic stress disorder.

Marijuana Moment: Veteran Access To Psychedelics Requires Balance Of Speed And Caution, Says Panel With VA And Former CDC Officials

Experts and advocates—including a Department of Veterans Affairs (VA) official and a former director of the Centers for Disease Control and Prevention (CDC)—recently convened for a Harvard University panel to discuss efforts to expand veteran access to psychedelic-assisted therapy.

Pharmacy Times: Psychedelic-Assisted Therapy Is Life-Changing for Veterans With PTSD, Yet Access to These Therapies Remain Outside the United States

Pharmacy Times interviewed Marcus Capone and Amber Capone, the co-founders of Veterans Exploring Treatment Solutions (VETS), on the current opportunities available for US veterans to seek psychedelic-assisted therapies for post-traumatic stress disorder (PTSD) and traumatic brain injuries (TBIs).

Bloomberg: Toms Shoes Founder Talks Funding Plan For Psychedelics Movement

Blake Mycoskie, the founder of Toms Shoes, announced earlier this year that he’d give $100 million to support research into the medical and mental health potential of psychedelic drugs.